[go: up one dir, main page]

RU2012103059A - METHOD FOR VITRIFICATION OF OVARIAN TISSUE - Google Patents

METHOD FOR VITRIFICATION OF OVARIAN TISSUE Download PDF

Info

Publication number
RU2012103059A
RU2012103059A RU2012103059/10A RU2012103059A RU2012103059A RU 2012103059 A RU2012103059 A RU 2012103059A RU 2012103059/10 A RU2012103059/10 A RU 2012103059/10A RU 2012103059 A RU2012103059 A RU 2012103059A RU 2012103059 A RU2012103059 A RU 2012103059A
Authority
RU
Russia
Prior art keywords
vitrification
kda
molecular weight
ovarian tissue
composition
Prior art date
Application number
RU2012103059/10A
Other languages
Russian (ru)
Inventor
Алексей Юрьевич Грязнов
Наталия Олеговна Мотовилова
Инна Валерьевна Миличенко
Ольга Евгеньевна Антропова
Николай Николаевич Рухляда
Игорь Чеславович Петкявичюс
Джамала Машкюр-кызы Гасымова
Мария Александровна Мельникова
Original Assignee
Алексей Юрьевич Грязнов
Наталия Олеговна Мотовилова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Алексей Юрьевич Грязнов, Наталия Олеговна Мотовилова filed Critical Алексей Юрьевич Грязнов
Priority to RU2012103059/10A priority Critical patent/RU2012103059A/en
Publication of RU2012103059A publication Critical patent/RU2012103059A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Способ витрификации яичниковой ткани, включающий поэтапное насыщение препарата проникающими криопротекторами, отличающийся тем, что для витрификации используют композицию состава:Диметилсульфоксид 19,52%Ацетамид 14,75%Этиленгликоль 15,51%,Полиэтиленгликоль с молекулярной массой 4 кДа 4%Яичный лецитин 4%Поливиниловый спирт молекулярной массой 6 кДа 1%Тетраполиглицерин 1%Кардиоплегический раствор ОстальноеA method of vitrification of ovarian tissue, including the stepwise saturation of the drug with penetrating cryoprotectants, characterized in that the composition is used for vitrification: Dimethyl sulfoxide 19.52% Acetamide 14.75% Ethylene glycol 15.51%, Polyethylene glycol with a molecular weight of 4 kDa 4% Egg lecithin 4% Polyvinyl alcohol with a molecular weight of 6 kDa 1% Tetrapolyglycerol 1% Cardioplegic solution

Claims (1)

Способ витрификации яичниковой ткани, включающий поэтапное насыщение препарата проникающими криопротекторами, отличающийся тем, что для витрификации используют композицию состава:A method of vitrification of ovarian tissue, including the gradual saturation of the drug with penetrating cryoprotectants, characterized in that a composition composition is used for vitrification: Диметилсульфоксид 19,52%Dimethyl sulfoxide 19.52% Ацетамид 14,75%Acetamide 14.75% Этиленгликоль 15,51%,Ethylene glycol 15.51%, Полиэтиленгликоль с молекулярной массой 4 кДа 4%Polyethylene glycol with a molecular weight of 4 kDa 4% Яичный лецитин 4%Egg Lecithin 4% Поливиниловый спирт молекулярной массой 6 кДа 1%Polyvinyl alcohol with a molecular weight of 6 kDa 1% Тетраполиглицерин 1%Tetrapoliglycerin 1% Кардиоплегический раствор Остальное Cardioplegic solution
RU2012103059/10A 2012-01-31 2012-01-31 METHOD FOR VITRIFICATION OF OVARIAN TISSUE RU2012103059A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2012103059/10A RU2012103059A (en) 2012-01-31 2012-01-31 METHOD FOR VITRIFICATION OF OVARIAN TISSUE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2012103059/10A RU2012103059A (en) 2012-01-31 2012-01-31 METHOD FOR VITRIFICATION OF OVARIAN TISSUE

Publications (1)

Publication Number Publication Date
RU2012103059A true RU2012103059A (en) 2013-08-10

Family

ID=49159110

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2012103059/10A RU2012103059A (en) 2012-01-31 2012-01-31 METHOD FOR VITRIFICATION OF OVARIAN TISSUE

Country Status (1)

Country Link
RU (1) RU2012103059A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019175597A1 (en) * 2018-03-16 2019-09-19 University Of Warwick Cryopreserving compositions

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019175597A1 (en) * 2018-03-16 2019-09-19 University Of Warwick Cryopreserving compositions

Similar Documents

Publication Publication Date Title
MX2015016303A (en) Use of tetramic acid derivatives as nematicides.
UY34605A (en) ARILALQUYLOXYPIRIMIDINE DERIVATIVES AND AGRICULTURAL INSECTICIDES THAT INCLUDE SUCH DERIVATIVES AS ACTIVE PRINCIPLES, AND THE METHOD OF USE OF THE SAME
UA122781C2 (en) PESTICIDELY ACTIVE HETEROCYCLIC DERIVATIVES WITH SULFUR-CONTAINING SUBSTITUENTS
EA201891182A1 (en) STABLE COMPOSITIONS WITH INOCULATOR AND METHODS FOR THEIR PRODUCTION
PE20151023A1 (en) TRIAZOLOPYRAZINES
NI201700011A (en) 2- (MORFOLIN-4-IL) -1,7-NAPHTHYRIDINES.
EA201891171A1 (en) STABLE COMPOSITIONS WITH INOCULATOR AND METHODS FOR THEIR PRODUCTION
MX341267B (en) COMBINATIONS OF ACTIVE PRINCIPLES WITH INSECTICIDES AND ACARICIDES.
BR112016026291A2 (en) BORONIC ACID DERIVATIVES AND THERAPEUTIC USES THEREOF
CL2013003287A1 (en) Compounds derived from 5-trifluoromethyl-4,5-dihydro-isoxazole; intermediate compounds; preparation procedure; pharmaceutical compositions comprising them; and use in the treatment of a parasite infestation in animals.
CY1120438T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING MY-INOSITOL AND D-KIRO-INOSITOL
CU20140081A7 (en) NEW DERIVATIVES OF PIRROL, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
EA201691194A1 (en) RHC STIMULATORS
UY34566A (en) 1,4? DIHYDROPIRIMIDINES 4.4? DISUSTITUTED AND ITS USE AS MEDICINES FOR THE TREATMENT OF HEPATITIS B
MX374915B (en) USE OF POLYMERIC EXCIPIENTS FOR LYOPHILIZATION OR FREEZING OF PARTICLES.
EP4628077A3 (en) LONG-LASTING SPIROISOXAZOLINE FORMULAS
CL2017000640A1 (en) New activators of soluble guanylate cyclase and its use
CR20170425A (en) NEW SPECIFIC PROTEINS FOR PIOVERDINA AND PIOQUELINA
MX2019006291A (en) CALCIUM LACTATE COMPOSITIONS AND METHODS OF USE.
MX380954B (en) CROSSLINKABLE COMPOSITION COMPRISING POLYETHYLENE AND USE THEREOF FOR ROTATIONAL MOLDING.
CO2018004573A2 (en) Phenyl derivatives as cannabinoid receptor 2 agonists
BR112016010828A2 (en) ? cheese processed with natural antibacterial and antimycotic components and manufacturing method?
UY35997A (en) ISOQUINOLEINE DERIVATIVES, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
CR20160016A (en) SUBSTITUTED PIRAZOLPIRIDINS
DOP2015000298A (en) NEW COMPOUNDS FOR CANCER TREATMENT

Legal Events

Date Code Title Description
FA94 Acknowledgement of application withdrawn (non-payment of fees)

Effective date: 20130909